Prim - Public Comps and Valuation Multiples

Prim Overview

About Prim

Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.

Founded

1966

HQ

Employees

563

Website

prim.es

Sectors

Medical Supplies

Financials

LTM Revenue $288M

LTM EBITDA $36.7M

EV

$272M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Prim Financials

As of September 2025, Prim reported last 12-month revenue of $288M and EBITDA of $36.7M.

In the same period, Prim achieved $17.6M in LTM net income.

See Prim valuation multiples based on analyst estimates

Prim P&L

In the most recent fiscal year, Prim reported revenue of $272M and EBITDA of $30.6M.

Prim expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Prim valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$288M	XXX	$272M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$130M	XXX	XXX	XXX
Gross Margin	n/a	XXX	48%	XXX	XXX	XXX
EBITDA	$36.7M	XXX	$30.6M	XXX	XXX	XXX
EBITDA Margin	13%	XXX	11%	XXX	XXX	XXX
EBIT	$23.7M	XXX	$16.3M	XXX	XXX	XXX
EBIT Margin	8%	XXX	6%	XXX	XXX	XXX
Net Profit	$17.6M	XXX	$12.7M	XXX	XXX	XXX
Net Margin	6%	XXX	5%	XXX	XXX	XXX
Net Debt	XXX	XXX	$3.4M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Prim including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $288M. EBITDA for the last twelve months was $36.7M. In the most recent fiscal year, Prim achieved $272M in revenue and $30.6M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$288M	Analyst estimates available to subscribers	$272M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$130M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	47.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$36.7M	Analyst estimates available to subscribers	$30.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.7% EBITDA margin	Analyst estimates available to subscribers	11.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$23.7M	Analyst estimates available to subscribers	$16.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.2% EBIT margin	Analyst estimates available to subscribers	6.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$17.6M	Analyst estimates available to subscribers	$12.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	6.1% net profit margin	Analyst estimates available to subscribers	4.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$3.4M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Prim

This financial data table provides comprehensive performance metrics for Prim, a company based in Spain. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Prim generated $288M in revenue over the last twelve months.
The company achieved $36.7M in EBITDA over the last twelve months.
Net income over the last twelve months reached $17.6M.

Fiscal Year Performance

In the most recent fiscal year, Prim reported $272M in total revenue.
Fiscal year EBITDA was $30.6M.
The company maintained a gross profit margin of 47.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 11.3%.
Net profit margin reached 4.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Prim. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Prim Stock Performance

Prim has current market cap of EUR 230M (or $268M), and EV of EUR 233M (or $272M).

Market Cap Evolution

Prim Stock Data

As of October 3, 2025, Prim's stock price is EUR 13 (or $16).

See Prim trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$272M	$268M	XXX	XXX	XXX	XXX	$1.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Prim Valuation Multiples

Prim's trades at 1.0x EV/Revenue multiple, and 8.9x EV/EBITDA.

See valuation multiples for Prim and 15K+ public comps

Prim Financial Valuation Multiples

As of October 3, 2025, Prim has market cap of $268M and EV of $272M.

Equity research analysts estimate Prim's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Prim has a P/E ratio of 15.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$268M	XXX	$268M	XXX	XXX	XXX
EV (current)	$272M	XXX	$272M	XXX	XXX	XXX
EV/Revenue	0.9x	XXX	1.0x	XXX	XXX	XXX
EV/EBITDA	7.4x	XXX	8.9x	XXX	XXX	XXX
EV/EBIT	11.5x	XXX	16.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	15.2x	XXX	21.0x	XXX	XXX	XXX
EV/FCF	n/a	XXX	21.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Prim Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Prim Margins & Growth Rates

Prim's last 12 month revenue growth is 8%

Prim's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Prim's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Prim's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Prim and other 15K+ public comps

Prim Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	13%	XXX	11%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	9%	XXX	XXX	XXX
Rule of 40	20%	XXX	19%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	32%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.5M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	42%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial